The TIM-3/gal-9 pathway is considered to have a critical role in immune suppression and immune escape for many types of cancer including HCC and it is gaining ground as an emerging target for future immunotherapy [17,18,19,20]. The gene discussed is HAVCR2; the disease is cancer.